Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dual Nature of Type I Interferons in SARS-CoV-2-Induced Inflammation
Charles M. King, Jonathan Sprent
Trends in Immunology (2021) Vol. 42, Iss. 4, pp. 312-322
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

SARS-CoV-2 Variants, Vaccines, and Host Immunity
Priyal Mistry, Fatima Barmania, Juanita Mellet, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 275
SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation
Bingyu Yan, Tilo Freiwald, Daniel Chauss, et al.
Science Immunology (2021) Vol. 6, Iss. 58
Open Access | Times Cited: 163
Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules
Matteo Stravalaci, Isabel Pagani, Elvezia Maria Paraboschi, et al.
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 275-286
Open Access | Times Cited: 128
A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 118
COVID-19 vaccine side effects: The positives about feeling bad
Jonathan Sprent, Charles M. King
Science Immunology (2021) Vol. 6, Iss. 60
Open Access | Times Cited: 114
Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis
Alba Grifoni, Tonino Alonzi, Galit Alter, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 49
Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2
Manon Venet, Margarida Sá Ribeiro, Élodie Décembre, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 39
Differential roles of interferons in innate responses to mucosal viral infections
Forrest C. Walker, Pratyush Sridhar, Megan T. Baldridge
Trends in Immunology (2021) Vol. 42, Iss. 11, pp. 1009-1023
Open Access | Times Cited: 86
Upregulated type I interferon responses in asymptomatic COVID-19 infection are associated with improved clinical outcome
Kiran Iqbal Masood, Maliha Yameen, Javeria Ashraf, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 75
Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein
Mustafa Yalcınkaya, Wenli Liu, Mohammad Naimul Islam, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 68
Pathogenesis of Respiratory Viral and Fungal Coinfections
Fabián Salazar, Elaine Bignell, Gordon D. Brown, et al.
Clinical Microbiology Reviews (2021) Vol. 35, Iss. 1
Open Access | Times Cited: 59
Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection
Jonas Schuhenn, Toni Luise Meister, Daniel Tödt, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 8
Open Access | Times Cited: 51
Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy
Mahdi Eskandarian Boroujeni, Agata Sekrecka, Aleksandra Antonczyk, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
COVID‐19 immunopathology: From acute diseases to chronic sequelae
Mohd Arish, Wei Qian, Harish Narasimhan, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 45
Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
Rupsha Fraser, Aurelio Orta‐Resendiz, Alexander Mazein, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 4, pp. 255-267
Open Access | Times Cited: 31
CRL4B E3 ligase recruited by PRPF19 inhibits SARS-CoV-2 infection by targeting ORF6 for ubiquitin-dependent degradation
Linran Zhang, Pengfei Hao, Xiang Chen, et al.
mBio (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 7
Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion
Alessio Mazzoni, Lorenzo Salvati, Laura Maggi, et al.
Seminars in Immunology (2021) Vol. 55, pp. 101508-101508
Open Access | Times Cited: 53
Circulating Type I Interferon Levels and COVID-19 Severity: A Systematic Review and Meta-Analysis
Rafaela Pires da Silva, João Ismael Budelon Gonçalves, Rafael Fernandes Zanin, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 43
Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype
Amelia Chiara Trombetta, Guilherme B. Farias, André M. C. Gomes, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 40
Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial
Christina Brennan, Sandeep Nadella, Xiang Zhao, et al.
Gut (2022) Vol. 71, Iss. 5, pp. 879-888
Open Access | Times Cited: 36
Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2
Jiajing Zheng, Jiameng Miao, Rui Guo, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 35
HDAC Inhibition as Potential Therapeutic Strategy to Restore the Deregulated Immune Response in Severe COVID-19
Chiara Ripamonti, Valeria Spadotto, Pietro Pozzi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Interferon at the crossroads of SARS-CoV-2 infection and COVID-19 disease
Charles E. Samuel
Journal of Biological Chemistry (2023) Vol. 299, Iss. 8, pp. 104960-104960
Open Access | Times Cited: 20
Novel mouse models based on intersectional genetics to identify and characterize plasmacytoid dendritic cells
Michael Valente, Nils Collinet, Thien‐Phong Vu Manh, et al.
Nature Immunology (2023) Vol. 24, Iss. 4, pp. 714-728
Open Access | Times Cited: 17
An Ionizable Lipid Material with a Vitamin E Scaffold as an mRNA Vaccine Platform for Efficient Cytotoxic T Cell Responses
Ryotaro Oyama, Harumichi Ishigame, Hiroki Tanaka, et al.
ACS Nano (2023) Vol. 17, Iss. 19, pp. 18758-18774
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top